Pacific Biosciences of California, Inc. (PACB)
USD 1.19
(0.42%)
USD 1.19
(0.42%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 56.67 Million USD | 12.49% |
| 2022 | 50.38 Million USD | 104.81% |
| 2021 | 24.59 Million USD | 72.87% |
| 2020 | 14.23 Million USD | 6.9% |
| 2019 | 13.31 Million USD | -25.54% |
| 2018 | 17.87 Million USD | -22.49% |
| 2017 | 23.06 Million USD | 47.53% |
| 2016 | 15.63 Million USD | 42.71% |
| 2015 | 10.95 Million USD | -3.35% |
| 2014 | 11.33 Million USD | 12.79% |
| 2013 | 10.05 Million USD | 4.77% |
| 2012 | 9.59 Million USD | -38.18% |
| 2011 | 15.51 Million USD | 126.06% |
| 2010 | 6.86 Million USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 67.34 Million USD | 18.82% |
| 2024 Q2 | 68.59 Million USD | 1.86% |
| 2023 FY | 56.67 Million USD | 12.49% |
| 2023 Q2 | 67.6 Million USD | 9.12% |
| 2023 Q3 | 68.25 Million USD | 0.96% |
| 2023 Q4 | 56.67 Million USD | -16.97% |
| 2023 Q1 | 61.95 Million USD | 22.97% |
| 2022 Q3 | 43.49 Million USD | 20.41% |
| 2022 Q4 | 50.38 Million USD | 15.83% |
| 2022 FY | 50.38 Million USD | 104.81% |
| 2022 Q1 | 29.62 Million USD | 20.43% |
| 2022 Q2 | 36.12 Million USD | 21.93% |
| 2021 Q2 | 17.98 Million USD | 10.55% |
| 2021 Q3 | 18.27 Million USD | 1.62% |
| 2021 Q4 | 24.59 Million USD | 34.6% |
| 2021 FY | 24.59 Million USD | 72.87% |
| 2021 Q1 | 16.26 Million USD | 14.32% |
| 2020 Q3 | 15.94 Million USD | -4.94% |
| 2020 Q2 | 16.76 Million USD | 3.99% |
| 2020 Q1 | 16.12 Million USD | 21.12% |
| 2020 Q4 | 14.23 Million USD | -10.73% |
| 2020 FY | 14.23 Million USD | 6.9% |
| 2019 Q1 | 19.65 Million USD | 9.91% |
| 2019 Q3 | 15.06 Million USD | -13.43% |
| 2019 FY | 13.31 Million USD | -25.54% |
| 2019 Q4 | 13.31 Million USD | -11.65% |
| 2019 Q2 | 17.4 Million USD | -11.43% |
| 2018 Q4 | 17.87 Million USD | -9.22% |
| 2018 FY | 17.87 Million USD | -22.49% |
| 2018 Q3 | 19.69 Million USD | -15.98% |
| 2018 Q1 | 25.93 Million USD | 12.42% |
| 2018 Q2 | 23.44 Million USD | -9.6% |
| 2017 Q3 | 18.2 Million USD | 5.42% |
| 2017 FY | 23.06 Million USD | 47.53% |
| 2017 Q4 | 23.06 Million USD | 26.72% |
| 2017 Q1 | 15.34 Million USD | -1.83% |
| 2017 Q2 | 17.26 Million USD | 12.5% |
| 2016 Q3 | 16.47 Million USD | 16.0% |
| 2016 FY | 15.63 Million USD | 42.71% |
| 2016 Q1 | 12.16 Million USD | 11.02% |
| 2016 Q2 | 14.2 Million USD | 16.77% |
| 2016 Q4 | 15.63 Million USD | -5.09% |
| 2015 Q4 | 10.95 Million USD | -5.73% |
| 2015 Q2 | 11.97 Million USD | -10.99% |
| 2015 Q1 | 13.45 Million USD | 18.72% |
| 2015 FY | 10.95 Million USD | -3.35% |
| 2015 Q3 | 11.62 Million USD | -2.98% |
| 2014 Q4 | 11.33 Million USD | -0.55% |
| 2014 Q3 | 11.39 Million USD | 20.74% |
| 2014 Q2 | 9.44 Million USD | 13.72% |
| 2014 FY | 11.33 Million USD | 12.79% |
| 2014 Q1 | 8.3 Million USD | -17.4% |
| 2013 Q2 | 10.28 Million USD | -2.96% |
| 2013 Q4 | 10.05 Million USD | 2.35% |
| 2013 Q3 | 9.81 Million USD | -4.51% |
| 2013 Q1 | 10.59 Million USD | 10.48% |
| 2013 FY | 10.05 Million USD | 4.77% |
| 2012 FY | 9.59 Million USD | -38.18% |
| 2012 Q4 | 9.59 Million USD | -5.98% |
| 2012 Q3 | 10.2 Million USD | -0.67% |
| 2012 Q2 | 10.27 Million USD | -13.11% |
| 2012 Q1 | 11.82 Million USD | -23.82% |
| 2011 Q2 | 19.55 Million USD | 44.41% |
| 2011 Q1 | 13.53 Million USD | 97.25% |
| 2011 Q4 | 15.51 Million USD | -23.42% |
| 2011 Q3 | 20.26 Million USD | 3.63% |
| 2011 FY | 15.51 Million USD | 126.06% |
| 2010 FY | 6.86 Million USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q4 | 6.86 Million USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 3.31 Million USD | -1612.266% |
| BrainsWay Ltd. | 3.71 Million USD | -1424.778% |
| Cerus Corporation | 39.86 Million USD | -42.159% |
| Envoy Medical, Inc. | 1.4 Million USD | -3936.752% |
| electroCore, Inc. | 2.16 Million USD | -2523.889% |
| Helius Medical Technologies, Inc. | 457 Thousand USD | -12301.751% |
| IceCure Medical Ltd | 2.27 Million USD | -2391.253% |
| Inogen, Inc. | 21.84 Million USD | -159.505% |
| OrthoPediatrics Corp. | 105.85 Million USD | 46.457% |
| Lucid Diagnostics Inc. | 278 Thousand USD | -20287.05% |
| Monogram Orthopaedics, Inc. | 1.00 USD | -5667599900.0% |
| MaxCyte, Inc. | 12.22 Million USD | -363.456% |
| NeuroOne Medical Technologies Corporation | 1.72 Million USD | -3182.357% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -36133.218% |
| Orthofix Medical Inc. | 222.16 Million USD | 74.489% |
| PAVmed Inc | 1.01 Million USD | -5472.867% |
| Rapid Micro Biosystems, Inc. | 19.96 Million USD | -183.934% |
| RxSight, Inc. | 17.42 Million USD | -225.331% |
| Sight Sciences, Inc. | 7.84 Million USD | -622.079% |
| SI-BONE, Inc. | 20.24 Million USD | -179.895% |
| TELA Bio, Inc. | 13.16 Million USD | -330.603% |
| Treace Medical Concepts, Inc. | 29.24 Million USD | -93.797% |
| Vivos Therapeutics, Inc. | 1.00 USD | -5667599900.0% |
| Acutus Medical, Inc. | 4.27 Million USD | -1224.825% |
| Talis Biomedical Corporation | - USD | -Infinity% |
| Spectral AI, Inc. | 230 Thousand USD | -24541.739% |
| Nano-X Imaging Ltd. | 2.35 Million USD | -2305.603% |
| CVRx, Inc. | 10.98 Million USD | -416.034% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 390.07 Thousand USD | -14429.476% |
| Bioventus Inc. | 91.33 Million USD | 37.946% |
| Venus Concept Inc. | 28.67 Million USD | -97.643% |
| TriSalus Life Sciences, Inc. | 2.54 Million USD | -2126.955% |
| LivaNova PLC | 147.88 Million USD | 61.676% |
| 908 Devices Inc. | 14.93 Million USD | -279.408% |
| Alphatec Holdings, Inc. | 136.84 Million USD | 58.583% |
| Nemaura Medical Inc. | 1.75 Million USD | -3129.674% |
| NeuroPace, Inc. | 11.21 Million USD | -405.404% |
| LENSAR, Inc. | 15.68 Million USD | -261.247% |
| Apyx Medical Corporation | 9.92 Million USD | -471.158% |
| Cutera, Inc. | 72.1 Million USD | 21.394% |
| STRATA Skin Sciences, Inc. | 2.67 Million USD | -2020.314% |
| BioSig Technologies, Inc. | -103 Thousand USD | 55125.243% |
| Anika Therapeutics, Inc. | 46.38 Million USD | -22.183% |
| ClearPoint Neuro, Inc. | 7.91 Million USD | -616.42% |
| Integra LifeSciences Holdings Corporation | 389.6 Million USD | 85.453% |
| Axonics, Inc. | 79.94 Million USD | 29.102% |
| Outset Medical, Inc. | 49.21 Million USD | -15.16% |
| IRIDEX Corporation | 9.9 Million USD | -472.138% |
| PROCEPT BioRobotics Corporation | 39.75 Million USD | -42.56% |
| IRadimed Corporation | 12.82 Million USD | -342.049% |
| Tivic Health Systems, Inc. | 756 Thousand USD | -7396.825% |
| INVO Bioscience, Inc. | 264.5 Thousand USD | -21327.032% |
| Telesis Bio, Inc. | 4.02 Million USD | -1308.099% |
| Viemed Healthcare, Inc. | 4.6 Million USD | -1130.931% |
| Varex Imaging Corporation | 277.5 Million USD | 79.576% |
| Quipt Home Medical Corp. | 18.32 Million USD | -209.27% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Pulmonx Corporation | 16.74 Million USD | -238.506% |
| Dynatronics Corporation | 5.59 Million USD | -913.162% |
| Modular Medical, Inc. | - USD | -Infinity% |
| ReShape Lifesciences Inc. | 3.74 Million USD | -1414.996% |
| Semler Scientific, Inc. | 445 Thousand USD | -12636.18% |
| InMode Ltd. | 45.09 Million USD | -25.681% |
| Bruker Corporation | 968.3 Million USD | 94.147% |
| Cytosorbents Corporation | 3.68 Million USD | -1440.055% |
| DexCom, Inc. | 559.6 Million USD | 89.872% |
| Align Technology, Inc. | 296.9 Million USD | 80.911% |
| Viveve Medical, Inc. | 1.47 Million USD | -3750.272% |
| ZimVie Inc. | 79.6 Million USD | 28.799% |
| Movano Inc. | 1.51 Million USD | -3645.935% |
| Cytek Biosciences, Inc. | 60.87 Million USD | 6.901% |
| Nexalin Technology, Inc. | 156.42 Thousand USD | -36133.218% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 157.93 Million USD | 64.115% |
| Profound Medical Corp. | 6.95 Million USD | -715.102% |
| Insulet Corporation | 402.6 Million USD | 85.923% |
| enVVeno Medical Corporation | - USD | -Infinity% |
| Surmodics, Inc. | 14.83 Million USD | -281.939% |
| iCAD, Inc. | 917 Thousand USD | -6080.589% |
| Nuwellis, Inc. | 1.99 Million USD | -2738.057% |
| Biotricity, Inc. | 1.87 Million USD | -2915.64% |
| iRhythm Technologies, Inc. | 13.97 Million USD | -305.611% |
| Aethlon Medical, Inc. | - USD | -Infinity% |
| InspireMD, Inc. | 2.1 Million USD | -2591.168% |
| PAVmed Inc. | 1.01 Million USD | -5472.867% |
| BIOLASE, Inc. | 11.43 Million USD | -395.723% |
| Beyond Air, Inc. | 2.12 Million USD | -2564.598% |
| FONAR Corporation | 2.71 Million USD | -1987.175% |
| AxoGen, Inc. | 23.02 Million USD | -146.203% |
| Vivani Medical, Inc. | - USD | -Infinity% |
| Tactile Systems Technology, Inc. | 22.52 Million USD | -151.591% |
| Inari Medical, Inc. | 42.9 Million USD | -32.112% |
| UFP Technologies, Inc. | 70.19 Million USD | 19.255% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 629.17 Thousand USD | -8907.929% |
| Tenon Medical, Inc. | 554 Thousand USD | -10130.325% |
| Autonomix Medical, Inc. Common Stock | - USD | -Infinity% |
| Co-Diagnostics, Inc. | 1.66 Million USD | -3304.526% |
| AdaptHealth Corp. | 113.64 Million USD | 50.128% |
| Sintx Technologies, Inc. | 888 Thousand USD | -6282.432% |
| NanoVibronix, Inc. | 2.73 Million USD | -1974.524% |
| Quanterix Corporation | 22.36 Million USD | -153.414% |
| Inspira Technologies Oxy B.H.N. Ltd. | - USD | -Infinity% |
| Sensus Healthcare, Inc. | 14.84 Million USD | -281.734% |
| TransMedics Group, Inc. | 44.23 Million USD | -28.125% |
| ReWalk Robotics Ltd. | 5.65 Million USD | -902.583% |
| NeuroMetrix, Inc. | 1.55 Million USD | -3534.41% |
| Hyperfine, Inc. | 6.58 Million USD | -761.076% |
| Establishment Labs Holdings Inc. | 79.93 Million USD | 29.101% |
| Biomerica, Inc. | 2.37 Million USD | -2285.354% |
| Bone Biologics Corporation | -328.84 Thousand USD | 17334.92% |
| AVITA Medical, Inc. | 3.12 Million USD | -1715.717% |
| Bluejay Diagnostics, Inc. | - USD | -Infinity% |
| Silk Road Medical, Inc | 29.87 Million USD | -89.704% |